|Slideshows|December 13, 2018
5 Classic Hallucinogens Studied in the Treatment of Addictions
Author(s)Michael P. Bogenschutz, MD
This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.
Advertisement
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Clears First and Only Single-Biomarker Blood Test for Alzheimer Disease Assessment
2
Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders
3
Kratom Component in Clinical Trial for Opioid Use Disorder
4
Migraine and Psychiatric Comorbidities
5